Drug · DIN 02462141 · Radiopharmaceutical
OSTEOVISION
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 29, 2021; first marketed January 31, 2019.
- Drug Identification Number (DIN)
- 02462141
- Company (DIN owner)
- Centre For Probe Development And CommercializationHamilton, Ontario, Canada
- Schedule
- Schedule C
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Sodium fluoride (18f) V09IX06
- Class
- Radiopharmaceutical
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SODIUM FLUORIDE F 18 | 11.1 GBQ | ML |